guvacine,
guvacine hydrobromide,
guvacine hydrochloride,
Guvacine hydrochloride,
6027-91-4,
1,2,5,6-tetrahydropyridine-3-carboxylic acid hydrochloride,
1,2,5,6-Tetrahydro-pyridine-3-carboxylic acid hydrochloride,
MLS000859975,
MFCD00055191,
SR-01000075614,
SMR000326834,
Guvacine HCl,
SPECTRUM1502126,
SCHEMBL1057880,
CHEMBL1256362,
CTK7I6002,
FGNUNVVTHHKDAM-UHFFFAOYSA-N,
ZX-CM014693,
Tox21_500571,
8985AB,
ACM498964,
ANW-67778,
BN0243,
CCG-38871,
AKOS015849631,
AKOS025243938,
LP00571,
MCULE-9382105537,
TRA0072680,
NCGC00093955-01,
NCGC00093955-02,
NCGC00093955-03,
NCGC00261256-01,
CS-13242,
EN000938,
AX8236874,
HY-100809,
TR-020835,
B6229,
CS-0020452,
EU-0100571,
FT-0669083,
G-007,
Y1163,
Guvacine hydrochloride, >=97% (NMR), solid,
1,2,5,6-Tetrahydronicotinic acid hydrochloride,
A13613,
Z-2043,
GUVACINE HYDROCHLORIDE >96% \ GABA UPTAK,
GUVACINE HYDROCHLORIDE gt96% \ GABA UPTAK,
SR-01000075614-1,
SR-01000075614-3,
SR-01000075614-6,
1,2,5,6-Terahydropyridine-3-carboxylic acid hydrochloride,
1,2,5,6-tetrahydro-3-pyridinecarboxylic acid, hydrochloride salt,
Guvacine,
hydrochloride,
Guvacine, hydrochloride,
C6H10ClNO2,
1,2,5,6-Tetrahydronicotinic acid,
CID11957555,
1,2,3,6-tetrahydropyridine-5-carboxylic acid,
498-96-4,
1,2,5,6-Tetrahydro-3-pyridinecarboxylic Acid Hydrochloride,
3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-, hydrochloride,
N/A,